Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jaillon

Showing results (161-170 of 195) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|February 16, 2007
Amiodarone interacts with simvastatin but not with pravastatin disposition kineticsL Becquemont, M Neuvonen, C Verstuyft, et al.
Annales De Cardiologie Et D'Angeiologie|May 30, 2009
[Management of atrial fibrillation in France: the observational FACTUEL study]P Mabo, A Leenhardt, P Jaillon, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Kinetics of medroxalol, a beta- and alpha-adrenoceptor antagonistK D Haegele, P Jaillon, G Cheymol, et al.
Clinical Pharmacology and Therapeutics|March 1, 1994
Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodaroneC Funck-Brentano, L Becquemont, H K Kroemer, et al.
Therapie|May 1, 1986
[Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine]R Leroyer, O Varoquaux, R Guillebastres, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1985
[Anti-arrhythmic effect of amiodarone in the 24 hours following a single oral loading dose. Clinical and pharmacological study]B Escoubet, J M Poirier, P Maison-Blanche, et al.
American Heart Journal|May 1, 1981
Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failureR C Feldman, R M Ball, M A Winchester, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1992
Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humansC Funck-Brentano, G Thomas, E Jacqz-Aigrain, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicityT Simon, L Becquemont, M Mary-Krause, et al.
Hepatology (Baltimore, Md.)|January 1, 1984
The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatinJ C Barbare, R Poupon, P Jaillon, et al.
Pageof 20

Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|February 16, 2007
Amiodarone interacts with simvastatin but not with pravastatin disposition kineticsL Becquemont, M Neuvonen, C Verstuyft, et al.
Annales De Cardiologie Et D'Angeiologie|May 30, 2009
[Management of atrial fibrillation in France: the observational FACTUEL study]P Mabo, A Leenhardt, P Jaillon, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Kinetics of medroxalol, a beta- and alpha-adrenoceptor antagonistK D Haegele, P Jaillon, G Cheymol, et al.
Clinical Pharmacology and Therapeutics|March 1, 1994
Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance, and interaction with amiodaroneC Funck-Brentano, L Becquemont, H K Kroemer, et al.
Therapie|May 1, 1986
[Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine]R Leroyer, O Varoquaux, R Guillebastres, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1985
[Anti-arrhythmic effect of amiodarone in the 24 hours following a single oral loading dose. Clinical and pharmacological study]B Escoubet, J M Poirier, P Maison-Blanche, et al.
American Heart Journal|May 1, 1981
Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failureR C Feldman, R M Ball, M A Winchester, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1992
Polymorphism of dextromethorphan metabolism: relationships between phenotype, genotype and response to the administration of encainide in humansC Funck-Brentano, G Thomas, E Jacqz-Aigrain, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicityT Simon, L Becquemont, M Mary-Krause, et al.
Hepatology (Baltimore, Md.)|January 1, 1984
The influence of vasoactive agents on metabolic activity of the liver in cirrhosis: a study of the effects of posterior pituitary extract, vasopressin, and somatostatinJ C Barbare, R Poupon, P Jaillon, et al.
Pageof 20